Gene Silencing

Phio Pharmaceuticals Advances siRNA Immunotherapy in Skin Cancer with INTASYL PH-762

Dateline — King of Prussia, Pennsylvania, November 7, 2025:Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has announced new clinical data from...

By cGxPwire Editor
November 9, 2025

Bio-Pharma

Phio Pharmaceuticals Strengthens Governance with New Lead Director

King of Prussia, Pennsylvania – October 31, 2025 — Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing...

By cGxPwire Editor
October 31, 2025

Bio-Pharma M&A

Arrowhead Pharma and Novartis Advance RNAi Therapy for Parkinson’s

Pasadena, CA – October 21, 2025 – Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has officially completed its global licensing and...

By cGxPwire Editor
October 21, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Phio Pharmaceuticals Advances siRNA Immunotherapy in Skin Cancer with INTASYL PH-762

Phio Pharmaceuticals Strengthens Governance with New Lead Director

Arrowhead Pharma and Novartis Advance RNAi Therapy for Parkinson’s